CATX Annual CFO
-$36.91 M
-$30.83 M-506.52%
01 December 2023
Summary:
As of January 23, 2025, CATX annual cash flow from operations is -$36.91 million, with the most recent change of -$30.83 million (-506.52%) on December 1, 2023. During the last 3 years, it has fallen by -$34.08 million (-1201.13%). CATX annual CFO is now -10204.85% below its all-time high of $365.30 thousand, reached on September 1, 1999.CATX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CATX Quarterly CFO
$3.37 M
+$12.27 M+137.81%
01 September 2024
Summary:
As of January 23, 2025, CATX quarterly cash flow from operations is $3.37 million, with the most recent change of +$12.27 million (+137.81%) on September 1, 2024. Over the past year, it has increased by +$13.48 million (+133.29%). CATX quarterly CFO is now -75.69% below its all-time high of $13.85 million, reached on March 1, 2024.CATX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CATX TTM CFO
-$696.00 K
+$13.48 M+95.09%
01 September 2024
Summary:
As of January 23, 2025, CATX TTM cash flow from operations is -$696.00 thousand, with the most recent change of +$13.48 million (+95.09%) on September 1, 2024. Over the past year, it has increased by +$27.21 million (+97.51%). CATX TTM CFO is now -290.48% below its all-time high of $365.40 thousand, reached on September 1, 1999.CATX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CATX Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -506.5% | +133.3% | +97.5% |
| 3 y3 years | -1201.1% | +134.6% | +95.2% |
| 5 y5 years | -631.1% | +134.6% | +95.2% |
CATX Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1201.1% | at low | -75.7% | +133.3% | at high | +98.1% |
| 5 y | 5-year | -1201.1% | at low | -75.7% | +133.3% | at high | +98.1% |
| alltime | all time | <-9999.0% | +37.6% | -75.7% | +133.3% | -290.5% | +98.1% |
Perspective Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.37 M(-137.8%) | -$696.00 K(-95.1%) |
| June 2024 | - | -$8.90 M(-164.3%) | -$14.17 M(+6.2%) |
| Mar 2024 | - | $13.85 M(-253.7%) | -$13.34 M(-63.9%) |
| Dec 2023 | -$36.91 M(+506.5%) | -$9.01 M(-10.9%) | -$36.91 M(+32.3%) |
| Sept 2023 | - | -$10.11 M(+25.2%) | -$27.91 M(+42.7%) |
| June 2023 | - | -$8.07 M(-17.0%) | -$19.56 M(+36.0%) |
| Mar 2023 | - | -$9.72 M(+451.5%) | -$14.38 M(+94.6%) |
| Dec 2022 | -$6.09 M(-21.1%) | - | - |
| Sept 2022 | - | -$1.76 M(-39.0%) | -$7.39 M(-4.2%) |
| June 2022 | - | -$2.89 M(+103.3%) | -$7.71 M(+29.9%) |
| June 2022 | -$7.71 M(+171.8%) | - | - |
| Mar 2022 | - | -$1.42 M(+8.3%) | -$5.94 M(+15.6%) |
| Dec 2021 | - | -$1.31 M(-37.0%) | -$5.14 M(+12.1%) |
| Sept 2021 | - | -$2.08 M(+86.4%) | -$4.58 M(+61.5%) |
| June 2021 | -$2.84 M(-22.1%) | - | - |
| June 2021 | - | -$1.12 M(+80.0%) | -$2.84 M(+10.5%) |
| Mar 2021 | - | -$621.00 K(-18.3%) | -$2.57 M(-8.6%) |
| Dec 2020 | - | -$760.00 K(+124.9%) | -$2.81 M(-15.6%) |
| Sept 2020 | - | -$338.00 K(-60.1%) | -$3.33 M(-8.7%) |
| June 2020 | -$3.64 M(-27.9%) | -$848.00 K(-1.6%) | -$3.64 M(-3.6%) |
| Mar 2020 | - | -$862.00 K(-32.6%) | -$3.78 M(-11.2%) |
| Dec 2019 | - | -$1.28 M(+95.7%) | -$4.25 M(+4.0%) |
| Sept 2019 | - | -$653.00 K(-33.7%) | -$4.09 M(-19.0%) |
| June 2019 | -$5.05 M(-11.6%) | -$985.00 K(-26.4%) | -$5.05 M(-8.4%) |
| Mar 2019 | - | -$1.34 M(+20.1%) | -$5.51 M(+4.9%) |
| Dec 2018 | - | -$1.11 M(-30.9%) | -$5.25 M(-7.2%) |
| Sept 2018 | - | -$1.61 M(+11.3%) | -$5.66 M(-0.9%) |
| June 2018 | -$5.71 M(0.0%) | -$1.45 M(+34.1%) | -$5.71 M(+4.3%) |
| Mar 2018 | - | -$1.08 M(-29.1%) | -$5.48 M(-6.9%) |
| Dec 2017 | - | -$1.52 M(-8.3%) | -$5.88 M(-2.3%) |
| Sept 2017 | - | -$1.66 M(+36.9%) | -$6.02 M(+5.4%) |
| June 2017 | -$5.71 M(+47.1%) | -$1.21 M(-18.3%) | -$5.71 M(+0.1%) |
| Mar 2017 | - | -$1.49 M(-10.6%) | -$5.71 M(+14.6%) |
| Dec 2016 | - | -$1.66 M(+22.8%) | -$4.98 M(+20.6%) |
| Sept 2016 | - | -$1.35 M(+12.0%) | -$4.13 M(+6.3%) |
| June 2016 | -$3.88 M(+10.3%) | -$1.21 M(+59.8%) | -$3.88 M(+17.5%) |
| Mar 2016 | - | -$756.00 K(-6.8%) | -$3.31 M(-10.3%) |
| Dec 2015 | - | -$811.00 K(-26.9%) | -$3.68 M(+5.6%) |
| Sept 2015 | - | -$1.11 M(+76.2%) | -$3.49 M(-1.0%) |
| June 2015 | -$3.52 M(+9.1%) | -$629.50 K(-44.5%) | -$3.52 M(-9.3%) |
| Mar 2015 | - | -$1.13 M(+84.7%) | -$3.88 M(+19.5%) |
| Dec 2014 | - | -$614.40 K(-46.3%) | -$3.25 M(-6.7%) |
| Sept 2014 | - | -$1.14 M(+15.6%) | -$3.48 M(+7.8%) |
| June 2014 | -$3.23 M(+5.6%) | -$989.00 K(+97.3%) | -$3.23 M(+6.7%) |
| Mar 2014 | - | -$501.20 K(-40.8%) | -$3.03 M(-7.8%) |
| Dec 2013 | - | -$846.00 K(-5.2%) | -$3.28 M(+9.0%) |
| Sept 2013 | - | -$892.00 K(+13.4%) | -$3.01 M(-1.5%) |
| June 2013 | -$3.06 M(+24.9%) | -$786.30 K(+3.9%) | -$3.06 M(+5.6%) |
| Mar 2013 | - | -$757.00 K(+31.8%) | -$2.89 M(-1.8%) |
| Dec 2012 | - | -$574.40 K(-38.8%) | -$2.95 M(+3.6%) |
| Sept 2012 | - | -$938.60 K(+50.5%) | -$2.84 M(+16.2%) |
| June 2012 | -$2.45 M(+1.2%) | -$623.60 K(-23.0%) | -$2.45 M(+0.5%) |
| Mar 2012 | - | -$810.10 K(+71.6%) | -$2.43 M(+13.5%) |
| Dec 2011 | - | -$472.00 K(-12.9%) | -$2.15 M(-7.6%) |
| Sept 2011 | - | -$542.10 K(-11.2%) | -$2.32 M(-4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2011 | -$2.42 M(-10.0%) | -$610.50 K(+17.2%) | -$2.42 M(-1.4%) |
| Mar 2011 | - | -$520.70 K(-19.6%) | -$2.45 M(-5.6%) |
| Dec 2010 | - | -$647.40 K(+1.1%) | -$2.60 M(-7.5%) |
| Sept 2010 | - | -$640.30 K(-0.8%) | -$2.81 M(+4.6%) |
| June 2010 | -$2.69 M(-32.0%) | -$645.20 K(-3.2%) | -$2.69 M(-9.2%) |
| Mar 2010 | - | -$666.30 K(-22.5%) | -$2.96 M(-3.9%) |
| Dec 2009 | - | -$859.30 K(+66.7%) | -$3.08 M(-11.4%) |
| Sept 2009 | - | -$515.60 K(-43.7%) | -$3.48 M(-12.0%) |
| June 2009 | -$3.95 M(-48.9%) | -$916.30 K(+16.4%) | -$3.95 M(-4.9%) |
| Mar 2009 | - | -$787.50 K(-37.3%) | -$4.15 M(-20.9%) |
| Dec 2008 | - | -$1.26 M(+27.0%) | -$5.24 M(-17.9%) |
| Sept 2008 | - | -$989.00 K(-11.5%) | -$6.39 M(-17.3%) |
| June 2008 | -$7.73 M(+7.3%) | -$1.12 M(-40.6%) | -$7.73 M(+2.8%) |
| Mar 2008 | - | -$1.88 M(-21.6%) | -$7.52 M(-7.7%) |
| Dec 2007 | - | -$2.40 M(+3.0%) | -$8.14 M(+8.1%) |
| Sept 2007 | - | -$2.33 M(+156.3%) | -$7.53 M(+4.6%) |
| June 2007 | -$7.20 M(+2.8%) | -$908.50 K(-63.8%) | -$7.20 M(-9.2%) |
| Mar 2007 | - | -$2.51 M(+40.3%) | -$7.93 M(+12.4%) |
| Dec 2006 | - | -$1.79 M(-10.4%) | -$7.05 M(-1.8%) |
| Sept 2006 | - | -$2.00 M(+22.0%) | -$7.18 M(+2.5%) |
| June 2006 | -$7.00 M(-88.2%) | -$1.64 M(+0.3%) | -$7.00 M(+30.5%) |
| Mar 2006 | - | -$1.63 M(-14.8%) | -$5.37 M(+43.6%) |
| Dec 2005 | - | -$1.92 M(+5.3%) | -$3.74 M(+104.8%) |
| Sept 2005 | - | -$1.82 M(>+9900.0%) | -$1.83 M(>+9900.0%) |
| June 2005 | -$59.17 M(>+9900.0%) | - | - |
| Mar 2005 | - | -$2400.00(-33.3%) | -$11.40 K(+7.5%) |
| Dec 2004 | - | -$3600.00(-5.3%) | -$10.60 K(+7.1%) |
| Sept 2004 | -$9900.00(-47.9%) | -$3800.00(+137.5%) | -$9900.00(-24.4%) |
| June 2004 | - | -$1600.00(0.0%) | -$13.10 K(-1.5%) |
| Mar 2004 | - | -$1600.00(-44.8%) | -$13.30 K(-7.6%) |
| Dec 2003 | - | -$2900.00(-58.6%) | -$14.40 K(-24.6%) |
| Sept 2003 | -$19.00 K(+113.5%) | -$7000.00(+288.9%) | -$19.10 K(+45.8%) |
| June 2003 | - | -$1800.00(-33.3%) | -$13.10 K(+2.3%) |
| Mar 2003 | - | -$2700.00(-64.5%) | -$12.80 K(-14.7%) |
| Dec 2002 | - | -$7600.00(+660.0%) | -$15.00 K(+68.5%) |
| Sept 2002 | -$8900.00(-39.5%) | -$1000.00(-33.3%) | -$8900.00(+1.1%) |
| June 2002 | - | -$1500.00(-69.4%) | -$8800.00(-51.4%) |
| Mar 2002 | - | -$4900.00(+226.7%) | -$18.10 K(+27.5%) |
| Dec 2001 | - | -$1500.00(+66.7%) | -$14.20 K(-4.1%) |
| Sept 2001 | -$14.70 K(+98.6%) | -$900.00(-91.7%) | -$14.80 K(-30.2%) |
| June 2001 | - | -$10.80 K(+980.0%) | -$21.20 K(+103.8%) |
| Mar 2001 | - | -$1000.00(-52.4%) | -$10.40 K(+10.6%) |
| Dec 2000 | - | -$2100.00(-71.2%) | -$9400.00(+28.8%) |
| Sept 2000 | -$7400.00(-102.0%) | -$7300.00(<-9900.0%) | -$7300.00(-102.8%) |
| June 2000 | - | $0.00(0.0%) | $261.50 K(+0.3%) |
| Mar 2000 | - | $0.00(0.0%) | $260.80 K(-0.2%) |
| Dec 1999 | - | $0.00(-100.0%) | $261.30 K(-28.5%) |
| Sept 1999 | $365.30 K(+32.4%) | $261.50 K(<-9900.0%) | $365.40 K(+251.7%) |
| June 1999 | - | -$700.00(-240.0%) | $103.90 K(-0.7%) |
| Mar 1999 | - | $500.00(-99.5%) | $104.60 K(+0.5%) |
| Dec 1998 | - | $104.10 K | $104.10 K |
| Sept 1998 | $276.00 K(-2459.0%) | - | - |
| Sept 1997 | -$11.70 K(-98.9%) | - | - |
| Sept 1996 | -$1.08 M(+115.8%) | - | - |
| Sept 1995 | -$501.80 K(-3.2%) | - | - |
| Sept 1994 | -$518.20 K | - | - |
FAQ
- What is Perspective Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Perspective Therapeutics?
- What is Perspective Therapeutics annual CFO year-on-year change?
- What is Perspective Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Perspective Therapeutics?
- What is Perspective Therapeutics quarterly CFO year-on-year change?
- What is Perspective Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Perspective Therapeutics?
- What is Perspective Therapeutics TTM CFO year-on-year change?
What is Perspective Therapeutics annual cash flow from operations?
The current annual CFO of CATX is -$36.91 M
What is the all time high annual CFO for Perspective Therapeutics?
Perspective Therapeutics all-time high annual cash flow from operations is $365.30 K
What is Perspective Therapeutics annual CFO year-on-year change?
Over the past year, CATX annual cash flow from operations has changed by -$30.83 M (-506.52%)
What is Perspective Therapeutics quarterly cash flow from operations?
The current quarterly CFO of CATX is $3.37 M
What is the all time high quarterly CFO for Perspective Therapeutics?
Perspective Therapeutics all-time high quarterly cash flow from operations is $13.85 M
What is Perspective Therapeutics quarterly CFO year-on-year change?
Over the past year, CATX quarterly cash flow from operations has changed by +$13.48 M (+133.29%)
What is Perspective Therapeutics TTM cash flow from operations?
The current TTM CFO of CATX is -$696.00 K
What is the all time high TTM CFO for Perspective Therapeutics?
Perspective Therapeutics all-time high TTM cash flow from operations is $365.40 K
What is Perspective Therapeutics TTM CFO year-on-year change?
Over the past year, CATX TTM cash flow from operations has changed by +$27.21 M (+97.51%)